These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 37879679)
1. Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials. Ibrahim Khalil A; Zhang L; Muwonge R; Sauvaget C; Basu P BMJ Open; 2023 Oct; 13(10):e069616. PubMed ID: 37879679 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis. Kechagias KS; Kalliala I; Bowden SJ; Athanasiou A; Paraskevaidi M; Paraskevaidis E; Dillner J; Nieminen P; Strander B; Sasieni P; Veroniki AA; Kyrgiou M BMJ; 2022 Aug; 378():e070135. PubMed ID: 35922074 [TBL] [Abstract][Full Text] [Related]
4. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549 [TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy and immunogenicity of therapeutic vaccines in the treatment of patients with high-grade cervical intraepithelial neoplasia associated with human papillomavirus: a systematic review protocol. Gonçalves CA; Lopes-Júnior LC; Nampo FK; Zilly A; Mayer PCM; Pereira-da-Silva G BMJ Open; 2019 Jul; 9(7):e026975. PubMed ID: 31320349 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis. Lichter K; Krause D; Xu J; Tsai SHL; Hage C; Weston E; Eke A; Levinson K Obstet Gynecol; 2020 May; 135(5):1070-1083. PubMed ID: 32282601 [TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
8. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test. van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial. van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis. Eriksen DO; Jensen PT; Schroll JB; Hammer A Acta Obstet Gynecol Scand; 2022 Jun; 101(6):597-607. PubMed ID: 35470865 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. Rambout L; Hopkins L; Hutton B; Fergusson D CMAJ; 2007 Aug; 177(5):469-79. PubMed ID: 17671238 [TBL] [Abstract][Full Text] [Related]
12. HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis. Mac Eochagain C; Power R; Parker I; Brennan D J Gynecol Oncol; 2022 May; 33(3):e24. PubMed ID: 35128855 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up. Harper DM; Nieminen P; Donders G; Einstein MH; Garcia F; Huh WK; Stoler MH; Glavini K; Attley G; Limacher JM; Bastien B; Calleja E Gynecol Oncol; 2019 Jun; 153(3):521-529. PubMed ID: 30955915 [TBL] [Abstract][Full Text] [Related]
15. Advances in therapeutic vaccines for treating human papillomavirus-related cervical intraepithelial neoplasia. Barra F; Della Corte L; Noberasco G; Foreste V; Riemma G; Di Filippo C; Bifulco G; Orsi A; Icardi G; Ferrero S J Obstet Gynaecol Res; 2020 Jul; 46(7):989-1006. PubMed ID: 32390320 [TBL] [Abstract][Full Text] [Related]
16. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial. Shing JZ; Hu S; Herrero R; Hildesheim A; Porras C; Sampson JN; Schussler J; Schiller JT; Lowy DR; Sierra MS; Carvajal L; Kreimer AR; Lancet Oncol; 2022 Jul; 23(7):940-949. PubMed ID: 35709811 [TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Grabosch SM; Shariff OM; Wulff JL; Helm CW Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD004121. PubMed ID: 24715225 [TBL] [Abstract][Full Text] [Related]
18. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Dillner J; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Maansson R; Lu S; Vuocolo S; Hesley TM; Saah A; Barr E; Haupt RM Cancer Prev Res (Phila); 2009 Oct; 2(10):868-78. PubMed ID: 19789295 [TBL] [Abstract][Full Text] [Related]
19. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test. Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis. van de Sande AJM; Kengsakul M; Koeneman MM; Jozwiak M; Gerestein CG; Kruse AJ; van Esch EMG; de Vos van Steenwijk PJ; Muntinga CLP; Bramer WM; van Doorn HC; van Kemenade FJ; van Beekhuizen HJ Int J Gynaecol Obstet; 2024 Jan; 164(1):66-74. PubMed ID: 37350560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]